Press Releases

Δ   04.26.10    MNTR Sees Shift To Public Acceptance

Δ   03.23.10    Cancer Index at New High with 12 Yr Exclusive Period in Health Bill

Δ   03.01.10    Provectus Pharmaceuticals (PVCT) added to Cancer Immunotherapy Index

Δ   01.19.10    MNTR Invests in 10 Cancer Index Companies

Δ   01.11.10    MNTR Retains Investment Bank to Assist Roll Out Cancer Immunotherapy Index Fund

Δ   12.14.09    2010 Actively Managed Cancer Immunotherapy Index Announced by MNTR

Δ   11.25.09     University Agreement Indicates Broad Cancer Application for QI Treatment

Δ   11.09.09     New Lab, Filings and JV Talks

Δ   09.30.09     MNTR Presents In NYC

Δ   07.15.09     Start of FDA Trials

Δ   07.15.09     QI Announces MNTR

Δ  07.10.09      MNTR Acquires First 20% of QI

Δ   09.06.08     MNTR Calls $3 Million Tranche

Δ   09.02.08     MNTR Initiates Trading